StockClub

EFTR

EFTReFFECTOR Therapeutics, Inc.$ --
eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc.

EFTR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2024FY2024 Q1
Revenue
0M USD
YoY -
Operating Income
-8M USD
YoY +12.0%
Net Income
-9M USD
YoY +11.8%
EPS
-3.31$
YoY +44.5%

Revenue

$0
FY2022 Q2$2M
$2M
Q2
FY2022 Q3$2M
$2M
Q3
FY2022 Q4$2M
$2M
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
FY2023 Q3$0
$0
Q3
FY2023 Q4$162,000
$162,000
Q4
FY2024 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-8.8M
FY2022 Q2$-3.8M
$-3.8M
Q2
FY2022 Q3$-13.4M
$-13.4M
Q3
FY2022 Q4$-22.7M
$-22.7M
Q4
FY2023 Q1$-10M
$-10M
Q1
FY2023 Q2$-18.4M
$-18.4M
Q2
FY2023 Q3$-26.7M
$-26.7M
Q3
FY2023 Q4$-35.8M
$-35.8M
Q4
FY2024 Q1$-8.8M
$-8.8M
Q1
Actual
+$1.2M (+11.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$0
FY2019
$0
FY2020
Actual:$42M
FY2020
$42M
FY2021BEAT
Actual:$1.4M
Est:$1.2M
FY2021BEAT
$1.4M
FY2022BEAT
Actual:$3.6M
Est:$3.6M
FY2022BEAT
$3.6M
FY2023IN-LINE
Actual:$0
Est:$0
FY2023IN-LINE
$0

Analyst Estimates